SHV-5 extended-spectrum β-lactamases in clinical isolates of Escherichia coli in Malaysia

Indian Journal of Medical Microbiology

Volumn 24, Issue 3, 2006, Pages 205-207

  Subramaniam, G ^a   Palasubramaniam, S ^a   Navaratnam, P ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

E. coli; Extended spectrum ; lactamases; SHV 5

Indexed keywords

CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE; SHV 5 BETA LACTAMASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE AMPLIFICATION; GENOTYPE; KLEBSIELLA PNEUMONIAE; MALAYSIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE;

EID: 33748181853     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ambler RP. The structure of β-lactamase. Philos Trans Soc London Ser B Biol Sci 1980;289:321-31.
2. Medeiros AA. Evolution of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 1997;24:19-45.
3. Ben-Hamouda T, Foulon T, Ben-Mahrez K. Involvement of SHV-12 and SHV-2a encoding plasmids in outbreaks of extended-spectrum β-lactamase producing Klebsiella pneumoniae in a Tunisian neonatal ward. Microb Drug Resist 2004;10:132-8.
4. Bauernfeind A, Rosenthal E, Eberlein E, Holley M, Schweighart S. Spread of Klebsiella pneumoniae producing SHV-5 β-lactamase among hospitalized patients. Infection 1993;21:18-22.
5. Poirel L, Lebessi E, Castro M, Fevre C, Foustoukov M, Nordmann P. Nosocomial outbreak of ESBL SHV-5 producing isolates of Pseudomonas aeruginosa in Athens, Greece. Antimicob Agents Chemother 2004;48:2277-9.
6. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards: Wayne, PA; 2000.
7. Neuwirth C, Siebor E, Lopez J, Pechinot A, Kazmierczak A. Outbreak of a TEM-24 producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum β-lactamase to other members of the family Enterobacteriaceae. J Clin Microbiol 1996;34:76-9.
8. M'Zali FH, Gascoyne-Binzi DM, Heritage J, Hawkey P. Detection of mutations conferring extended-spectrum activity of SHV β-lactamases using polymerase chain reaction single-stranded conformational polymorphism (PCR-SSCP). J Antimicrob Chemother 1996;37:797-802.
9. Paterson DL, Rossi F, Baquero F, Hsieh PR, Woods GL, Satischandran V, et al. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide. J Antimicrob Chemother 2005;55:965-73.
10. Prodinger WM, Fille M, Bauernfiend A, Stempliger I, Amann S, Pfausler B, et al. Molecular epidemiology of Klebsiella pneumoniae-producing SHV-5 β-lactamase. J Clin Microbiol 1996;34:564-8.
11. Palasubramaniam S. Characterization of extended-spectrum β-lactamases from multi-resistant strains of Klebsiella pneumoniae. Masters Thesis, University of Malaya: Kuala Lumpur; 1998.
12. Venezia RA, Scarano FJ, Preston KE, Steele LM, Root TM, Limberger R, et al. Molecular epidemiology of an SHV-5 extended-spectrum beta lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit. Clin Infect Dis 1995;21:915-23.
13. Heritage J, M'Zali FH, Gascoyne-Binzi D, Hawkey PM. Evolution and spread of SHV extended-spectrum β-lactamases in Gram-negative bacteria. J Antimicrob Chemother 1999;44:309-18.